3-52322488-C-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_015512.5(DNAH1):c.46C>T(p.Gln16Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,613,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000013 ( 0 hom. )
Consequence
DNAH1
NM_015512.5 stop_gained
NM_015512.5 stop_gained
Scores
1
1
5
Clinical Significance
Conservation
PhyloP100: -0.383
Genes affected
DNAH1 (HGNC:2940): (dynein axonemal heavy chain 1) This gene encodes an inner dynein arm heavy chain that provides structural support between the radial spokes and the outer doublet of the sperm tail. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and multiple morphological anomalies of the flagella that result in asthenozoospermia and male infertility. Mice with a homozygous knockout of the orthologous gene are viable but have reduced sperm motility and are infertile. [provided by RefSeq, Feb 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 6 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-52322488-C-T is Pathogenic according to our data. Variant chr3-52322488-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1453969.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH1 | NM_015512.5 | c.46C>T | p.Gln16Ter | stop_gained | 2/78 | ENST00000420323.7 | NP_056327.4 | |
DNAH1 | XM_017006129.2 | c.46C>T | p.Gln16Ter | stop_gained | 3/80 | XP_016861618.1 | ||
DNAH1 | XM_017006130.2 | c.46C>T | p.Gln16Ter | stop_gained | 3/79 | XP_016861619.1 | ||
DNAH1 | XM_017006131.2 | c.46C>T | p.Gln16Ter | stop_gained | 3/79 | XP_016861620.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH1 | ENST00000420323.7 | c.46C>T | p.Gln16Ter | stop_gained | 2/78 | 1 | NM_015512.5 | ENSP00000401514 | P1 | |
DNAH1 | ENST00000486752.5 | n.307C>T | non_coding_transcript_exon_variant | 2/77 | 2 | |||||
DNAH1 | ENST00000497875.1 | n.211C>T | non_coding_transcript_exon_variant | 3/21 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152154Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
28
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000443 AC: 11AN: 248358Hom.: 0 AF XY: 0.0000445 AC XY: 6AN XY: 134820
GnomAD3 exomes
AF:
AC:
11
AN:
248358
Hom.:
AF XY:
AC XY:
6
AN XY:
134820
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461158Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 726876
GnomAD4 exome
AF:
AC:
19
AN:
1461158
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
726876
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000184 AC: 28AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74450
GnomAD4 genome
AF:
AC:
28
AN:
152272
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
7
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 13, 2020 | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with DNAH1-related conditions. This variant is present in population databases (rs199910432, ExAC 0.07%). This sequence change creates a premature translational stop signal (p.Gln16*) in the DNAH1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAH1 are known to be pathogenic (PMID: 27573432, 27798045). - |
Spermatogenic failure 18 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Apr 04, 2024 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 14, 2024 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Reported among a cohort of individuals with cardiovascular disease traits; however, no detailed clinical information was provided (PMID: 31345219); This variant is associated with the following publications: (PMID: 31345219) - |
DNAH1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 18, 2024 | The DNAH1 c.46C>T variant is predicted to result in premature protein termination (p.Gln16*). This variant was reported in an individual with cardiovascular disease (Table S1, Glicksberg et al 2019. PubMed ID: 31345219). This variant is reported in 0.075% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at